BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu W, Lu L, Feng Y, Chen J, Li Y, Kong X, Chen S, Li X, Chen Q, Zhang P. Inflammation promotes oral squamous carcinoma immune evasion via induced programmed death ligand-1 surface expression. Oncol Lett 2013;5:1519-26. [PMID: 23761816 DOI: 10.3892/ol.2013.1238] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Luo M, Xia Y, Wang F, Zhang H, Su D, Su C, Yang C, Wu S, An S, Lin S, Fu L. PD0325901, an ERK inhibitor, enhances the efficacy of PD-1 inhibitor in non-small cell lung carcinoma. Acta Pharm Sin B 2021;11:3120-33. [PMID: 34729305 DOI: 10.1016/j.apsb.2021.03.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
2 Cui B, Chen J, Luo M, Wang L, Chen H, Kang Y, Wang J, Zhou X, Feng Y, Zhang P. Protein kinase D3 regulates the expression of the immunosuppressive protein, PD‑L1, through STAT1/STAT3 signaling. Int J Oncol 2020;56:909-20. [PMID: 32319563 DOI: 10.3892/ijo.2020.4974] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
3 Li X, Lian Z, Wang S, Xing L, Yu J. Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC. Cancer Letters 2018;418:1-9. [DOI: 10.1016/j.canlet.2018.01.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 8.6] [Reference Citation Analysis]
4 Derakhshandeh R, Sanadhya S, Lee Han K, Chen H, Goloubeva O, Webb TJ, Younis RH. Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype. Oncotarget 2018;9:11126-44. [PMID: 29541402 DOI: 10.18632/oncotarget.24277] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu Z, Ravindranathan R, Kalinski P, Guo ZS, Bartlett DL. Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy. Nat Commun 2017;8:14754. [PMID: 28345650 DOI: 10.1038/ncomms14754] [Cited by in Crossref: 183] [Cited by in F6Publishing: 208] [Article Influence: 30.5] [Reference Citation Analysis]
6 Weichselbaum RR, Liang H, Deng L, Fu Y. Radiotherapy and immunotherapy: a beneficial liaison? Nat Rev Clin Oncol 2017;14:365-79. [DOI: 10.1038/nrclinonc.2016.211] [Cited by in Crossref: 540] [Cited by in F6Publishing: 564] [Article Influence: 90.0] [Reference Citation Analysis]
7 Khatami M. THE EYES HAVE IT ALL! Inflammation, Aging and Cancer 2017. [DOI: 10.1007/978-3-319-66475-0_4] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Shah S, Caruso A, Cash H, Waes CV, Allen CT. Pools of programmed death-ligand within the oral cavity tumor microenvironment: Variable alteration by targeted therapies. Head Neck 2016;38:1176-86. [PMID: 27061215 DOI: 10.1002/hed.24269] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
9 de Sousa LVNF, Santos VL, de Souza Monteiro A, Dias-Souza MV, Marques SG, de Faria ES, Assunção EAO, Dos Santos SG, Zonis JM, de Alvarenga DG, de Holanda RA, de Sousa JG, Dos Santos KV, Stoianoff MAR. Isolation and identification of Candida species in patients with orogastric cancer: susceptibility to antifungal drugs, attributes of virulence in vitro and immune response phenotype. BMC Infect Dis 2016;16:86. [PMID: 26905729 DOI: 10.1186/s12879-016-1431-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhang J, Wang CM, Zhang P, Wang X, Chen J, Yang J, Lu W, Zhou W, Yuan W, Feng Y. Expression of programmed death 1 ligand 1 on periodontal tissue cells as a possible protective feedback mechanism against periodontal tissue destruction. Mol Med Rep. 2016;13:2423-2430. [PMID: 26847035 DOI: 10.3892/mmr.2016.4824] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
11 Shrimali RK, Janik JE, Abu-Eid R, Mkrtichyan M, Khleif SN. Programmed death-1 & its ligands: promising targets for cancer immunotherapy. Immunotherapy 2015;7:777-92. [PMID: 26250412 DOI: 10.2217/imt.15.49] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
12 Lim YZ, South AP. Tumour-stroma crosstalk in the development of squamous cell carcinoma. Int J Biochem Cell Biol 2014;53:450-8. [PMID: 24955488 DOI: 10.1016/j.biocel.2014.06.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
13 Khatami M. Chronic Inflammation: Synergistic Interactions of Recruiting Macrophages (TAMs) and Eosinophils (Eos) with Host Mast Cells (MCs) and Tumorigenesis in CALTs. M-CSF, Suitable Biomarker for Cancer Diagnosis! Cancers (Basel) 2014;6:297-322. [PMID: 24473090 DOI: 10.3390/cancers6010297] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]